View Author
Muchmore, E.
( E. Muchmore)
9 h 9 hbsag 4-7 b 4-7 hbs.ot anti- chimpanzee phase hbs.ot 40 anti-hb antibody mouse conjugate amount sample chimpanzee hbsag anti-pre assay complex hbs.ot 42 inhibition experiment mouse hbs.ot 40 serum epitope particle phase anti-pres 1 phase anti-s virus hepatitis result binding hbsag particles dilution treatment pres 1 protein infusion 30 min sample 30 min heijtink protein peptide curve hbs.ot 3m incubation phase hbs.ot 3m level liver transplant recipients antigen phase mouse detection activity signal organon teknika abbott laboratories chimpanzee pre-treatment hbsag 6 ng \ml concentration surface 9 h 9\4-7b 4-7 b antibodies titrated absorbance pres 1 assay mixture phase 4-7 b epitope region acid treatment 450 nm circulation ausria ii vivo activity hbsag eia hbsag \ayw reduction teknika pre-treatment titrated amount anti-pres 1 titrated amounts
1 Most Recent Publications
|
In vivo activity of a mixture of two human monoclonal antibodies (anti-HBs) in a chronic hepatitis B virus carrier chimpanzee
(Article)
Heijtink, R. Paulij, W. Bergen, P. van Roosmalen, M.H. van Rohm, D. Eichentopf, B. Muchmore, E. Osterhaus, A.D.M.E. Man, R.A. de |
1999-01-01
|